The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging

Investigative Radiology

Volumn 49, Issue 9, 2014, Pages 608-619

  Goetschi, Stefan ^a   Froehlich, Johannes M ^b   Chuck, Natalie C ^a   Curcio, Raffaele ^c   Runge, Val M ^a   Andreisek, Gustav ^a   Nanz, Daniel ^a   Boss, Andreas ^a  

^a University Hospital Zurich Institut fur Diagnostische Radiologie   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

contrast agent relaxivity; contrast enhanced MR imaging; gadolinium based contrast agents; human blood serum proteins; relaxometry

Indexed keywords

ALBUMIN; CONTRAST MEDIUM; GADOBUTROL; GADOFOSVESET; GADOTERATE MEGLUMINE; GADOXETIC ACID; IMMUNOGLOBULIN G; PROTEIN; GADOLINIUM; GADOLINIUM PENTETATE; MEGLUMINE; ORGANOMETALLIC COMPOUND; PLASMA PROTEIN;

ALBUMIN BLOOD LEVEL; AQUEOUS SOLUTION; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; HUMAN; IMAGE ANALYSIS; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RELAXOMETRY; STATISTICAL ANALYSIS; DIAGNOSTIC USE; PROCEDURES;

BLOOD PROTEINS; CONTRAST MEDIA; GADOLINIUM; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PROTEINS;

EID: 84905816956     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000061     Document Type: Conference Paper

References (23)

1. Bellin MF, Van Der Molen AJ. Extracellular gadolinium-based contrast media: an overview. Eur J Radiol. 2008;66:160-167.
2. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724. (Pubitemid 41546838)
3. Lauffer RB. Targeted relaxation enhancement agents for MRI. Magn Reson Med. 1991;22:339-342.
4. Stanisz GJ, Henkelman RM. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med. 2000;44:665-667.
5. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents. Invest Radiol. 2006;41:222-228. (Pubitemid 44406182)
6. Wang Y, Spiller M, Caravan P. Evidence for weak protein binding of commercial extracellular gadolinium contrast agents. Magn Reson Med. 2010;63: 609-616.
7. Caravan P, Cloutier NJ, Greenfield MT, et al. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc. 2002;124:3152-3162. (Pubitemid 34249987)
8. Caravan P. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc Chem Res. 2009; 42:851-862.
9. Fasano M, Curry S, Terreno E, et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life. 2005;57:787-796. (Pubitemid 43062399)
10. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 1949;177:751-766.
11. Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825-3280.
12. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med. 2005;54:507-512.
13. DiCiccio TJ, Efron B. Bootstrap confidence intervals. Stat Sci. 1996;11:189-212.
14. Vavricka SR, Burri E, Beglinger C, et al. Serum protein electrophoresis: an underused but very useful test. Digestion. 2009;79:203-210.
15. Henrotte V, Vander Elst L, Laurent S, et al. Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin. J Biol Inorg Chem. 2007;12:929-937. (Pubitemid 47174882)
16. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 tesla. Invest Radiol. 2006;41:213-221. (Pubitemid 44406181)
17. Noebauer-Huhmann IM, Szomolanyi P, Juras V, et al. Gadolinium-based magnetic resonance contrast agents at 7 tesla: in vitro T1 relaxivities in human blood plasma. Invest Radiol. 2010;45:554-558.
18. Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging. 2006;1:128-137.
19. Adzamli K, Vander Elst L, Laurent S, et al. Deuterium NMR study of the MP-2269: albumin interactionVa step forward to the dynamics of non-covalent binding. MAGMA. 2001;12:92-95. (Pubitemid 32510125)
20. Vander Elst L, Laurent S, Bintoma HM, et al. Albumin-bound MRI contrast agents: the dilemma of the rotational correlation time. MAGMA. 2001;12: 135-140. (Pubitemid 32510132)
21. Aragon SR. Recent advances in macromolecular hydrodynamic modeling. Methods. 2011;54:101-114.
22. Kratz F, Elsadek B. Clinical impact of serum proteins on drug delivery. J Control Release. 2012;161:429-445.
23. Nanz D, Gö tschi S, Froehlich JM, et al. On contrast-enhanced MR imaging in the presence of pathological plasma-protein concentrations [abstract]. ISMRM. 2014. Abstract 558.